The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Yoshio Honma

Saitama Cancer Center Research Institute

Japan

[email]@*.*.saitama.jp

Name/email consistency: high

[Claim this account]

Affiliations

Saitama Cancer Center Research Institute, Japan. 2000 - 2003
Saitama Cancer Center Research Institute, 818 Komuro, Ina, Saitama 362-0806, Japan. 2002 - 2003

References

Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice. Honma, Y., Ishii, Y., Yamamoto-Yamaguchi, Y., Sassa, T., Asahi, K. Cancer Res. (2003) [Pubmed]
Treatment of human promyelocytic leukemia in the SCID mouse model with cotylenin A, an inducer of myelomonocytic differentiation of leukemia cells. Honma, Y., Ishii, Y., Sassa, T., Asahi, K. Leuk. Res. (2003) [Pubmed]
Cotylenin A--a plant growth regulator as a differentiation-inducing agent against myeloid leukemia. Honma, Y. Leuk. Lymphoma (2002) [Pubmed]
Differentiation of human myeloid leukemia cells by plant redifferentiation-inducing hormones. Honma, Y., Ishii, Y. Leuk. Lymphoma (2002) [Pubmed]
Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives. Honma, Y., Ishii, Y., Kasukabe, T., Okabe-Kado, J., Yamamoto-Yamaguchi, Y., Kakegawa, T., Awaya, A. Exp. Hematol. (2001) [Pubmed]
A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors. Honma, Y. Leuk. Lymphoma (2001) [Pubmed]
Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia. Honma, Y., Niitsu, N. Leuk. Lymphoma (2000) [Pubmed]